Ridgewood, NJ, United States of America

Mohammed R Marzabadi

This inventor holds 4 USPTO granted patents. Top assignee: Synaptic Pharmaceutical Corporation. Active years: 1998-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohammed R Marzabadi. Retrieved from https://idiyas.com/inventor/mohammed-r-marzabadi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1998-2003

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mohammed R Marzabadi

Introduction

Mohammed R Marzabadi is a notable inventor based in Ridgewood, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 4 patents to his name, Marzabadi's work has the potential to impact various medical treatments.

Latest Patents

One of his latest patents is focused on dihydropyridines and their new uses. This invention provides dihydropyridines that are useful for the treatment of prostatic hyperplasia, inhibition of cholesterol synthesis, and/or reduction of intraocular pressure. Another patent related to this topic outlines a method for treating benign prostatic hyperplasia in a subject by administering a therapeutically effective amount of a compound with a specific structure.

Career Highlights

Marzabadi is currently associated with Synaptic Pharmaceutical Corporation, where he continues to develop innovative solutions in the pharmaceutical industry. His work is characterized by a commitment to improving patient outcomes through scientific advancements.

Collaborations

He has collaborated with notable colleagues such as Charles Gluchowski and John M Wetzel, contributing to a dynamic research environment that fosters innovation.

Conclusion

Mohammed R Marzabadi's contributions to the field of pharmaceuticals through his patents demonstrate his dedication to advancing medical treatments. His work continues to inspire and pave the way for future innovations in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…